Psychosocial outcomes with the Omnipod® 5 Automated Insulin Delivery System in caregivers of very young children with type 1 diabetes
Authors' conclusion
Caregivers face unique challenges when managing T1D in very young children. While glycaemic metrics have unquestioned importance, these results evaluating psychosocial outcomes reveal additional meaningful benefits and suggest that the Omnipod 5 AID System alleviates some of the burdens caregivers face with diabetes management.
Study context
- Population
- Caregivers of children aged 2.0–5.9 years with T1Dchildren enrolled
- Participants
- 80 participants
- Comparison
- Omnipod 5 automated insulin delivery (AID) System vs baseline standard therapy
- Omnipod 5n = 80
- Outcome
- Caregiver psychosocial outcomes
- Follow-up
- 3 months
Methodological detailsmulticentre
- Multicentre
Main finding
As reported in the abstract
- Caregivers experienced significant improvements across all measures
- Omnipod 5 vs Standard therapy: P < 0.0001
- Omnipod 5 vs Standard therapy: P < 0.01
- Omnipod 5 vs Standard therapy: P < 0.0001
- Omnipod 5 vs Standard therapy: P < 0.0001
- Omnipod 5 vs Standard therapy: all p < 0.05
- Omnipod 5 vs Standard therapy: all p < 0.0001
Original publication
Psychosocial outcomes with the Omnipod® 5 Automated Insulin Delivery System in caregivers of very young children with type 1 diabetes. Diabetes Obes Metab. Published 20 September 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →